Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
Trade with 70% Backtested Accuracy
Analyst Views on SIGA
About SIGA
About the author
SIGA Technologies to Host Business Update Call on March 10, 2026
- Conference Call Details: SIGA Technologies will host a business update call on March 10, 2026, at 4:30 PM ET, featuring CEO Diem Nguyen and CFO Daniel Luckshire, aimed at enhancing investor confidence in the company's future direction.
- Participation Instructions: Investors can join the call by dialing 1-800-717-1738 for domestic participants or 1-646-307-1865 for international callers, with a recommendation to log in 5-10 minutes early to ensure smooth access.
- Replay Availability: A replay of the call will be accessible for two weeks, with domestic callers using 1-844-512-2921 and international callers using 1-412-317-6671, referencing Conference ID 1122478, allowing those unable to attend live to catch up on key information.
- Company Overview: SIGA Technologies is a commercial-stage pharmaceutical company focused on developing innovative medicines to combat infectious diseases, particularly orthopoxviruses, and is committed to providing essential countermeasures against global health threats through partnerships with governments and public health agencies.
Daily Upgrade Report for Validea Motley Fool Strategy - September 4, 2025
Stock Upgrade: SIGA Technologies Inc. received an upgrade in its rating from 53% to 80% based on the Motley Fool's small-cap growth investor strategy, indicating increased interest in the stock due to its strong fundamentals and valuation.
Company Overview: SIGA Technologies is a pharmaceutical company focused on developing antiviral medicines, with its flagship product TPOXX approved for treating smallpox and other orthopoxvirus-related diseases in various regions.
Validea Motley Fool Strategy Daily Upgrade Report - 8/12/2025
Stock Ratings Overview: Validea's Small-Cap Growth Investor model, based on Motley Fool's strategy, has upgraded several small-cap stocks including REX American Resources Corp, WM Technology Inc, Bank7 Corp, and SIGA Technologies Inc, reflecting improved ratings due to strong fundamentals and valuations.
Company Descriptions: Each company operates in distinct sectors such as chemical manufacturing, software for cannabis businesses, banking, and biotechnology, with specific focuses ranging from ethanol production to antiviral medicines, showcasing a diverse investment landscape.
Why Siga Technologies Inc. (SIGA) Dipped More Than Broader Market Today
Stock Performance: Siga Technologies Inc. (SIGA) closed at $6.36, down 1.24%, but has seen an 8.78% increase over the past month, outperforming both the Medical sector and the S&P 500.
Earnings and Analyst Estimates: The upcoming earnings report is anticipated, with estimates showing a significant drop in earnings per share but an increase in revenue; SIGA currently holds a Zacks Rank of #3 (Hold), indicating stable analyst confidence.
SIGA Technologies declares $0.60 dividend
Special Dividend Announcement: SIGA Technologies has declared a special dividend of $0.60 per share, payable on May 15 for shareholders recorded as of April 29, with an ex-dividend date also set for April 29.
Company Insights: The article includes additional information on SIGA Technologies' financial performance, including historical earnings data and insights from their Q4 2024 earnings call.
Siga Technologies Inc. (SIGA) Stock Sinks As Market Gains: What You Should Know
Siga Technologies Inc. Stock Performance: Siga Technologies Inc. (SIGA) closed at $5.48, down 1.26%, underperforming the S&P 500's gain of 0.55%. The company is projected to report earnings of $0.13 per share and revenue of $184.36 million for the year, reflecting significant declines in earnings estimates.
Analyst Estimates and Zacks Rank: Recent analyst revisions indicate a negative outlook for Siga, with a Zacks Rank of #4 (Sell) and an EPS estimate drop of 89.6% over the past month. The stock trades at a high Forward P/E ratio of 42.69 compared to its industry average of 16.44, suggesting it is overvalued relative to peers.
SIGA Technologies to Host Business Update Call on March 10, 2026
- Conference Call Details: SIGA Technologies will host a business update call on March 10, 2026, at 4:30 PM ET, featuring CEO Diem Nguyen and CFO Daniel Luckshire, aimed at enhancing investor confidence in the company's future direction.
- Participation Instructions: Investors can join the call by dialing 1-800-717-1738 for domestic participants or 1-646-307-1865 for international callers, with a recommendation to log in 5-10 minutes early to ensure smooth access.
- Replay Availability: A replay of the call will be accessible for two weeks, with domestic callers using 1-844-512-2921 and international callers using 1-412-317-6671, referencing Conference ID 1122478, allowing those unable to attend live to catch up on key information.
- Company Overview: SIGA Technologies is a commercial-stage pharmaceutical company focused on developing innovative medicines to combat infectious diseases, particularly orthopoxviruses, and is committed to providing essential countermeasures against global health threats through partnerships with governments and public health agencies.
Daily Upgrade Report for Validea Motley Fool Strategy - September 4, 2025
Stock Upgrade: SIGA Technologies Inc. received an upgrade in its rating from 53% to 80% based on the Motley Fool's small-cap growth investor strategy, indicating increased interest in the stock due to its strong fundamentals and valuation.
Company Overview: SIGA Technologies is a pharmaceutical company focused on developing antiviral medicines, with its flagship product TPOXX approved for treating smallpox and other orthopoxvirus-related diseases in various regions.
Validea Motley Fool Strategy Daily Upgrade Report - 8/12/2025
Stock Ratings Overview: Validea's Small-Cap Growth Investor model, based on Motley Fool's strategy, has upgraded several small-cap stocks including REX American Resources Corp, WM Technology Inc, Bank7 Corp, and SIGA Technologies Inc, reflecting improved ratings due to strong fundamentals and valuations.
Company Descriptions: Each company operates in distinct sectors such as chemical manufacturing, software for cannabis businesses, banking, and biotechnology, with specific focuses ranging from ethanol production to antiviral medicines, showcasing a diverse investment landscape.
Why Siga Technologies Inc. (SIGA) Dipped More Than Broader Market Today
Stock Performance: Siga Technologies Inc. (SIGA) closed at $6.36, down 1.24%, but has seen an 8.78% increase over the past month, outperforming both the Medical sector and the S&P 500.
Earnings and Analyst Estimates: The upcoming earnings report is anticipated, with estimates showing a significant drop in earnings per share but an increase in revenue; SIGA currently holds a Zacks Rank of #3 (Hold), indicating stable analyst confidence.
SIGA Technologies declares $0.60 dividend
Special Dividend Announcement: SIGA Technologies has declared a special dividend of $0.60 per share, payable on May 15 for shareholders recorded as of April 29, with an ex-dividend date also set for April 29.
Company Insights: The article includes additional information on SIGA Technologies' financial performance, including historical earnings data and insights from their Q4 2024 earnings call.
Siga Technologies Inc. (SIGA) Stock Sinks As Market Gains: What You Should Know
Siga Technologies Inc. Stock Performance: Siga Technologies Inc. (SIGA) closed at $5.48, down 1.26%, underperforming the S&P 500's gain of 0.55%. The company is projected to report earnings of $0.13 per share and revenue of $184.36 million for the year, reflecting significant declines in earnings estimates.
Analyst Estimates and Zacks Rank: Recent analyst revisions indicate a negative outlook for Siga, with a Zacks Rank of #4 (Sell) and an EPS estimate drop of 89.6% over the past month. The stock trades at a high Forward P/E ratio of 42.69 compared to its industry average of 16.44, suggesting it is overvalued relative to peers.
